Clinical trials
Cardiomyopathy, Dilated trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 7 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 9 |
| Barts & The London NHS Trust | 2 |
| Bristol-Myers Squibb | 2 |
| Ethicare GmbH | 2 |
| University College, London | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Pfizer | 1 |
| Tenaya Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Dilated | 26 |
| Heart Failure | 8 |
| Cardiomyopathies | 6 |
| Cardiomyopathy, Hypertrophic | 4 |
| Death, Sudden, Cardiac | 3 |
| Heart Diseases | 2 |
| Myocardial Infarction | 2 |
| Arrhythmias, Cardiac | 1 |
| Arrhythmogenic Right Ventricular Dysplasia | 1 |
| Campomelic Dysplasia | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.